[Primary headaches in children with hydrocephalus who have a ventriculoperitoneal bypass valve].

Rev Neurol

Centro de Rehabilitación Infantil Evandro Carlos de Andrade, Río de Janeiro, Brazil.

Published: September 2005

Introduction: Headache, which is the clinical manifestation of intracranial hypertension, is also a clinical ailment in medical practice, as well as one of the main causes of visits in the paediatric age. Determining whether this symptom is secondary or not to a decompensation of the intracranial pressure in children with hydrocephalus is sometimes a challenging task. The aim of this study is to classify the headaches in a population of children with a ventriculoperitoneal bypass valve due to hydrocephalus.

Patients And Methods: We conducted a study of a series of cases with a longitudinal follow-up. 20 children with a ventriculoperitoneal bypass valve owing to hydrocephalus were followed up over a mean period of eight months because they suffered from recurring headaches. All of them answered a questionnaire in order to define the characteristics of their headache. Those who were suspected of suffering from intracranial hypertension were submitted to a cerebral tomography study.

Results: In all, we studied 20 patients (eight males and 12 females) with a mean age of 8.6 +/- 2.8 years. Hydrocephalus was secondary to abnormalities in the craniocervical transition and myelomeningocele in all cases. The aetiology of the headache was primary migraine-type headache (14 patients; 70%), and tension-type headache (two patients; 10%). Secondary headaches appeared in four patients (20%) due to acute sinusitis, refraction errors and systemic infection; only one patient had headache due to intracranial hypertension.

Conclusions: Migraine predominates as the primary headache in children with bypass valves--a phenomenon that can be explained by its high prevalence in the paediatric population.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ventriculoperitoneal bypass
12
children hydrocephalus
8
intracranial hypertension
8
children ventriculoperitoneal
8
bypass valve
8
headache patients
8
headache
7
children
5
[primary headaches
4
headaches children
4

Similar Publications

Disseminated tuberculosis (TB) is a TB infection involving two or more noncontiguous sites. It is a challenging medical care due to its misleading presentation. Although it is associated with immunodepression, rare cases have been described in immunocompetent patients.

View Article and Find Full Text PDF

Decompressive craniectomy (DC) is performed for refractory intracranial hypertension following severe traumatic brain injury, vascular and oncological diseases. This fact increases the number of patients with extensive and giant skull defects. Cerebrospinal fluid (CSF) flow disorders after DC are often accompanied by ventriculomegaly.

View Article and Find Full Text PDF

Sonolucent Cranial Implants: A Window into the Future of Management of Neurosurgical Patients? A Systematic Review and Cost Analysis.

World Neurosurg

January 2024

Department of Neurosurgery, Hackensack Meridian School of Medicine, Nutley, New Jersey, USA; Department of Neurosurgery, HMH-Jersey Shore University Medical Center, Neptune, New Jersey, USA.

Background: Computeed tomography (CT) is a cornerstone of the identification and management of acute changes in neurosurgery patients. In addition to the monetary expense of CT scans, further costs are incurred due to the time of patient transport and radiation exposure. Ultrasounds (USs)offer a safe, inexpensive, and bedside alternative to CT but obstacles remain due to decreased penetrance in the adult skull.

View Article and Find Full Text PDF

Post-traumatic hydrocephalus (PTH) is treated through cerebrospinal fluid (CSF) diversion, typically through ventriculoperitoneal shunt (VPS) or other bypass techniques. As these shunts are associated with significant complications and high revision rates in certain populations, it is important to tailor a patient's shunt procedure according to their medical history and complications. Herein, we report the case of a 30-year-old man with PTH following a traffic accident on a motorcycle.

View Article and Find Full Text PDF

Background And Purpose: Prasugrel (Pra) is a third-generation thienopyridine that inhibits platelet aggregation via irreversible blockade of P2Y12 receptors. While several published studies have examined the use of Pra and acetylsalicylic acid (ASA) in coronary and neurovascular stenting procedures, there is only anecdotal evidence regarding the use of Pra as single antiplatelet therapy (SAPT) in open surgical procedures. This topic has become important because previous studies have revealed that neurovascular devices with antithrombotic coatings can be implanted using non-invasive procedures in patients maintained on Pra SAPT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!